OBJECTIVE: To characterize renal macrophages and dendritic cells (DCs) in 2 murine models of lupus nephritis. METHODS: We used a bead-based enrichment step followed by cell sorting to isolate populations of interest from young mice and nephritic mice. Cell morphology was examined by microscopy. Arginase and nitrite production was examined using biochemical assays. The antigen-presenting functions of the cells were determined using mixed lymphocyte reactions. Selected cytokine, chemokine, and Toll-like receptor (TLR) profiles were examined using real-time quantitative polymerase chain reaction. RESULTS: We identified 2 populations of macrophages and 3 populations of DCs in both of our murine models of lupus (NZB/NZW and [NZW × BXSB]F1 mice). F4/80(high) macrophages, which were resident in normal kidneys and found to be increased in number during nephritis, did not produce either arginase or nitrite upon cytokine stimulation and acquired a mixed proinflammatory and antiinflammatory functional phenotype during nephritis that resembles the constitutively activated phenotype of gut F4/80(high) macrophages. The various cell types differed in their expression of chemokine receptors and TLRs, consistent with variability in their renal location. Resident renal CD103+ DCs were the best antigen-presenting cells and could easily be distinguished from CD11c(high) myeloid DCs that accumulated in large numbers during nephritis. CONCLUSION: Our study highlights the heterogeneity of the macrophage/DC infiltrate in chronic lupus nephritis and provides an initial phenotypic and functional analysis of the different cellular components that can now be used to define the role of each cell subset in nephritis progression or amelioration. Of note, the dominant macrophage population that accumulates during nephritis has an acquired phenotype that is neither M1 nor M2 and may reflect failure of resolution of inflammation.
OBJECTIVE: To characterize renal macrophages and dendritic cells (DCs) in 2 murine models of lupus nephritis. METHODS: We used a bead-based enrichment step followed by cell sorting to isolate populations of interest from young mice and nephritic mice. Cell morphology was examined by microscopy. Arginase and nitrite production was examined using biochemical assays. The antigen-presenting functions of the cells were determined using mixed lymphocyte reactions. Selected cytokine, chemokine, and Toll-like receptor (TLR) profiles were examined using real-time quantitative polymerase chain reaction. RESULTS: We identified 2 populations of macrophages and 3 populations of DCs in both of our murine models of lupus (NZB/NZW and [NZW × BXSB]F1 mice). F4/80(high) macrophages, which were resident in normal kidneys and found to be increased in number during nephritis, did not produce either arginase or nitrite upon cytokine stimulation and acquired a mixed proinflammatory and antiinflammatory functional phenotype during nephritis that resembles the constitutively activated phenotype of gut F4/80(high) macrophages. The various cell types differed in their expression of chemokine receptors and TLRs, consistent with variability in their renal location. Resident renal CD103+ DCs were the best antigen-presenting cells and could easily be distinguished from CD11c(high) myeloid DCs that accumulated in large numbers during nephritis. CONCLUSION: Our study highlights the heterogeneity of the macrophage/DC infiltrate in chronic lupus nephritis and provides an initial phenotypic and functional analysis of the different cellular components that can now be used to define the role of each cell subset in nephritis progression or amelioration. Of note, the dominant macrophage population that accumulates during nephritis has an acquired phenotype that is neither M1 nor M2 and may reflect failure of resolution of inflammation.
Authors: Oscar Medina-Contreras; Duke Geem; Oskar Laur; Ifor R Williams; Sergio A Lira; Asma Nusrat; Charles A Parkos; Timothy L Denning Journal: J Clin Invest Date: 2011-12 Impact factor: 14.808
Authors: Florian Leuschner; Philipp J Rauch; Takuya Ueno; Rostic Gorbatov; Brett Marinelli; Won Woo Lee; Partha Dutta; Ying Wei; Clinton Robbins; Yoshiko Iwamoto; Brena Sena; Aleksey Chudnovskiy; Peter Panizzi; Edmund Keliher; John M Higgins; Peter Libby; Michael A Moskowitz; Mikael J Pittet; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf Journal: J Exp Med Date: 2012-01-02 Impact factor: 14.307
Authors: Teja Celhar; Richard Hopkins; Susannah I Thornhill; Raquel De Magalhaes; Sun-Hee Hwang; Hui-Yin Lee; Hiroko Yasuga; Leigh A Jones; Jose Casco; Bernett Lee; Thomas P Thamboo; Xin J Zhou; Michael Poidinger; John E Connolly; Edward K Wakeland; Anna-Marie Fairhurst Journal: Proc Natl Acad Sci U S A Date: 2015-10-28 Impact factor: 11.205
Authors: Melissa A Cunningham; Mara Lennard Richard; Jena R Wirth; Jennifer L Scott; Jackie Eudaly; Phil Ruiz; Gary S Gilkeson Journal: J Autoimmun Date: 2018-11-08 Impact factor: 7.094
Authors: X Liao; J Ren; A Reihl; T Pirapakaran; B Sreekumar; T E Cecere; C M Reilly; X M Luo Journal: Clin Exp Immunol Date: 2017-08-18 Impact factor: 4.330